Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

[Langerhans cell histiocytosis of the stomach with BRAF-V600E-mutation: case report and review of the literature].

Sarbia M, Mauerer R, Bettstetter M, Funk A.

Z Gastroenterol. 2015 Apr;53(4):302-5. doi: 10.1055/s-0034-1399058. Epub 2015 Apr 10. Review. German.

PMID:
25860580
2.

High-grade dysplasia, restricted to the basal cell layer involving the entire esophagus.

Sarbia M, Wolfer S, Karimi D, Eimiller A.

World J Gastroenterol. 2015 Feb 7;21(5):1663-5. doi: 10.3748/wjg.v21.i5.1663.

3.

Multi-colour FISH in oesophageal adenocarcinoma-predictors of prognosis independent of stage and grade.

Geppert CI, Rümmele P, Sarbia M, Langer R, Feith M, Morrison L, Pestova E, Schneider-Stock R, Hartmann A, Rau TT.

Br J Cancer. 2014 Jun 10;110(12):2985-95. doi: 10.1038/bjc.2014.238. Epub 2014 May 22.

4.

Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics.

Rau TT, Agaimy A, Gehoff A, Geppert C, Jung K, Knobloch K, Langner C, Lugli A, Groenbus-Lurkin I, Nagtegaal ID, Rüschoff J, Saegert X, Sarbia M, Schneider-Stock R, Vieth M, Zwarthoff EC, Hartmann A.

Virchows Arch. 2014 Jun;464(6):663-72. doi: 10.1007/s00428-014-1569-7. Epub 2014 Apr 12.

PMID:
24728704
5.

Foveolar gastric metaplasia of the duodenum: a frequent, so far neglected type of duodenal polyp.

Sarbia M, Sauer G, Karimi D, Berndt R.

Z Gastroenterol. 2014 Apr;52(4):348-50. doi: 10.1055/s-0033-1355693. Epub 2014 Apr 9.

PMID:
24718939
6.

[Serrated polyps of the duodenum. Three cases with immunohistological and molecular pathological findings].

Sarbia M, Jüttner S, Bettstetter M, Berndt R.

Pathologe. 2013 Jul;34(4):347-51. doi: 10.1007/s00292-013-1754-5. German.

PMID:
23440291
7.

[Paraneoplastic acanthosis nigricans of the esophagus: a case report].

Sarbia M, Ringelhan M, Siveke J, Bettstetter M, Karimi D.

Z Gastroenterol. 2012 Jul;50(7):680-3. doi: 10.1055/s-0031-1299503. Epub 2012 Jul 3. German.

PMID:
22760680
8.

EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Geddert H, zur Hausen A, Gabbert HE, Sarbia M.

Cell Oncol (Dordr). 2011 Jun;34(3):209-14. doi: 10.1007/s13402-011-0028-6. Epub 2011 May 3.

PMID:
21538028
9.

EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Geddert H, Zur Hausen A, Gabbert HE, Sarbia M.

Anal Cell Pathol (Amst). 2010;33(3):143-9. doi: 10.3233/ACP-CLO-2010-0540.

10.

Gorlin syndrome associated with small bowel carcinoma and mesenchymal proliferation of the gastrointestinal tract: case report and review of literature.

Prodinger PM, Sarbia M, Massmann J, Straka C, Meyer G, Steinlein OK.

BMC Cancer. 2010 Jul 7;10:360. doi: 10.1186/1471-2407-10-360.

11.

The predictive value of genes of the TGF-beta1 pathway in multimodally treated squamous cell carcinoma of the esophagus.

Pühringer-Oppermann F, Sarbia M, Ott N, Brücher BL.

Int J Colorectal Dis. 2010 Apr;25(4):515-21. doi: 10.1007/s00384-009-0867-z. Epub 2009 Dec 15.

PMID:
20012971
12.

EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis.

Möller K, Papanikolaou IS, Toermer T, Delicha EM, Sarbia M, Schenck U, Koch M, Al-Abadi H, Meining A, Schmidt H, Schulz HJ, Wiedenmann B, Rösch T.

Gastrointest Endosc. 2009 Jul;70(1):60-9. doi: 10.1016/j.gie.2008.10.008. Epub 2009 Apr 25.

PMID:
19394012
13.

Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway.

Twarock S, Röck K, Sarbia M, Weber AA, Jänicke RU, Fischer JW.

Br J Pharmacol. 2009 May;157(2):234-43. doi: 10.1111/j.1476-5381.2009.00138.x. Epub 2009 Mar 26.

14.

Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas.

Friederichs J, von Weyhern CW, Rosenberg R, Doll D, Busch R, Lordick F, Siewert JR, Sarbia M.

Langenbecks Arch Surg. 2010 Apr;395(4):373-9. doi: 10.1007/s00423-009-0478-8. Epub 2009 Mar 12.

PMID:
19280218
15.

Testicular metastasis from adenocarcinoma of the esophagus.

Gillen S, Feith M, Gertler R, Langer R, Massmann J, Sarbia M, Friess H.

Ann Thorac Surg. 2009 Mar;87(3):957-9. doi: 10.1016/j.athoracsur.2008.07.115.

PMID:
19231438
16.

Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone.

Nehls O, Hass HG, Okech T, Zenner S, Hsieh CJ, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Porschen R, Gregor M, Klump B.

Int J Colorectal Dis. 2009 Jun;24(6):655-63. doi: 10.1007/s00384-009-0635-0. Epub 2009 Feb 17.

PMID:
19221769
17.

Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia.

Anders M, Rösch T, Küster K, Becker I, Höfler H, Stein HJ, Meining A, Wiedenmann B, Sarbia M.

Cancer Gene Ther. 2009 Jun;16(6):508-15. doi: 10.1038/cgt.2008.103. Epub 2009 Jan 9.

PMID:
19132065
18.

Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database.

von Rahden BH, Stein HJ, Weber A, Vieth M, Stolte M, Rösch T, Schmid RM, Sarbia M, Meining A.

Dis Esophagus. 2008;21(8):685-9. doi: 10.1111/j.1442-2050.2008.00857.x.

PMID:
18847456
19.

[Endoscopic ultrasound-guided biopsy: diagnostic yield, pitfalls, quality management].

Jenssen C, Möller K, Wagner S, Sarbia M.

Z Gastroenterol. 2008 Sep;46(9):897-908. doi: 10.1055/s-2008-1027419. Epub 2008 Sep 22. Review. German.

PMID:
18810676
20.

Expression of EpCam and villin in Barrett's esophagus and in gastric cardia.

Anders M, Sarbia M, Grotzinger C, Meining A, Hofler H, Wiedenmann B, Rosch T.

Dis Markers. 2008;24(6):287-92.

21.

[Endoscopic ultrasound-guided biopsy: diagnostic yield, pitfalls, quality management part 1: optimizing specimen collection and diagnostic efficiency].

Jenssen C, Möller K, Wagner S, Sarbia M.

Z Gastroenterol. 2008 Jun;46(6):590-600. doi: 10.1055/s-2008-1027413. Review. German.

PMID:
18537087
22.

Expression of prostaglandin E synthase in Barrett's cancer.

von Rahden BH, Stein HJ, Hartl SA, Theisen J, Stigler B, Siewert JR, Sarbia M.

Dis Esophagus. 2008;21(4):304-8. doi: 10.1111/j.1442-2050.2007.00801.x.

PMID:
18477251
23.

Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer.

Wiech T, Nikolopoulos E, Lassman S, Heidt T, Schöpflin A, Sarbia M, Werner M, Shimizu Y, Sakka E, Ooka T, zur Hausen A.

Virchows Arch. 2008 Jun;452(6):621-7. doi: 10.1007/s00428-008-0594-9. Epub 2008 Apr 25.

PMID:
18437417
24.

Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer.

Walch A, Seidl S, Hermannstädter C, Rauser S, Deplazes J, Langer R, von Weyhern CH, Sarbia M, Busch R, Feith M, Gillen S, Höfler H, Luber B.

Mod Pathol. 2008 May;21(5):544-52. doi: 10.1038/modpathol.2008.3. Epub 2008 Feb 1.

25.

Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET.

Beer AJ, Niemeyer M, Carlsen J, Sarbia M, Nährig J, Watzlowik P, Wester HJ, Harbeck N, Schwaiger M.

J Nucl Med. 2008 Feb;49(2):255-9. doi: 10.2967/jnumed.107.045526. Epub 2008 Jan 16.

26.

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.

Beer AJ, Grosu AL, Carlsen J, Kolk A, Sarbia M, Stangier I, Watzlowik P, Wester HJ, Haubner R, Schwaiger M.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6610-6.

27.

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.

Sarbia M, Ott N, Pühringer-Oppermann F, Brücher BL.

Br J Cancer. 2007 Nov 19;97(10):1404-8. Epub 2007 Oct 16.

28.
29.

Differentiation between pancreaticobiliary and upper gastrointestinal adenocarcinomas: is analysis of cytokeratin 17 expression helpful?

Sarbia M, Fritze F, Geddert H, von Weyhern C, Rosenberg R, Gellert K.

Am J Clin Pathol. 2007 Aug;128(2):255-9.

PMID:
17638659
30.

Analysis of the E-cadherin repressor Snail in primary human cancers.

Becker KF, Rosivatz E, Blechschmidt K, Kremmer E, Sarbia M, Höfler H.

Cells Tissues Organs. 2007;185(1-3):204-12. Review.

PMID:
17587826
31.

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.

Nehls O, Okech T, Hsieh CJ, Enzinger T, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Hass HG, Arkenau HT, Hartmann JT, Porschen R, Gregor M, Klump B.

Br J Cancer. 2007 May 7;96(9):1409-18. Epub 2007 Apr 10.

32.

Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin.

Castro Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M, Carneiro F, Becker KF.

J Pathol. 2007 Apr;211(5):507-15.

PMID:
17299729
33.

Squamous cell carcinoma and Zenker diverticulum.

Brücher BL, Sarbia M, Oestreicher E, Molls M, Burian M, Biemer E, Stein HJ.

Dis Esophagus. 2007;20(1):75-8.

PMID:
17227315
34.

Lack of EGFR gene mutations in exons 19 and 21 in esophageal (Barrett's) adenocarcinomas.

Pühringer-Oppermann FA, Stein HJ, Sarbia M.

Dis Esophagus. 2007;20(1):9-11.

PMID:
17227303
36.

c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression.

von Rahden BH, Stein HJ, Pühringer-Oppermann F, Sarbia M.

Neoplasia. 2006 Sep;8(9):702-7.

37.

Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.

von Rahden BH, Stein HJ, Feith M, Pühringer F, Theisen J, Siewert JR, Sarbia M.

Mol Carcinog. 2006 Oct;45(10):786-94.

PMID:
16921482
38.

[Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].

Langer R, Specht K, Becker K, Ewald P, Sarbia M, Busch R, Feith M, Stein HJ, Siewert JR, Höfler H.

Verh Dtsch Ges Pathol. 2004;88:207-13. German.

PMID:
16892554
39.

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL, Schnell O, Niemeyer M, Kessler H, Wester HJ, Weber WA, Schwaiger M.

Clin Cancer Res. 2006 Jul 1;12(13):3942-9.

40.

Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.

Langer R, Von Rahden BH, Nahrig J, Von Weyhern C, Reiter R, Feith M, Stein HJ, Siewert JR, Höfler H, Sarbia M.

J Clin Pathol. 2006 Jun;59(6):631-4.

41.

Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel.

Brücher BL, Geddert H, Langner C, Höfler H, Fink U, Siewert JR, Sarbia M.

Int J Cancer. 2006 Sep 15;119(6):1298-302.

42.

The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.

Brücher BL, Becker K, Lordick F, Fink U, Sarbia M, Stein H, Busch R, Zimmermann F, Molls M, Höfler H, Siewert JR.

Cancer. 2006 May 15;106(10):2119-27.

43.

Esophageal squamous cell carcinoma with entirely intramural growth pattern.

von Rahden BH, Brücher BL, Sarbia M.

Virchows Arch. 2006 Jun;448(6):862-6. Epub 2006 Mar 28.

PMID:
16572347
44.

Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction.

Pühringer-Oppermann F, Stahl M, Keller G, Sarbia M.

J Cancer Res Clin Oncol. 2006 Jul;132(7):433-8. Epub 2006 Mar 15.

PMID:
16538517
45.

Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases.

Lordick F, Geinitz H, Theisen J, Sendler A, Sarbia M.

Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1295-8. Epub 2006 Feb 28.

PMID:
16503384
46.

The histological appearance of oesophageal adenocarcinoma--an analysis based on 215 resection specimens.

Sarbia M.

Virchows Arch. 2006 May;448(5):532-8. Epub 2006 Feb 24.

PMID:
16498532
47.

No association of primary adenocarcinomas of the small bowel with Epstein-Barr virus infection.

von Rahden BH, Langner C, Brücher BL, Stein HJ, Sarbia M.

Mol Carcinog. 2006 May;45(5):349-52.

PMID:
16493667
48.

The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma.

Baumann S, Keller G, Pühringer F, Napieralski R, Feith M, Langer R, Höfler H, Stein HJ, Sarbia M.

Int J Cancer. 2006 Jul 15;119(2):264-8.

49.

Medical Image. Combined FDG-PET/CT and CT-guided biopsy in diagnosing oesophageal cancer recurrence.

von Rahden BH, Sarbia M, Stein HJ.

N Z Med J. 2006 Jan 27;119(1228):U1810. No abstract available.

PMID:
16462920
50.

Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.

Grote HJ, Schmiemann V, Geddert H, Bocking A, Kappes R, Gabbert HE, Sarbia M.

Cancer. 2006 Apr 25;108(2):129-34.

Supplemental Content

Loading ...
Support Center